Why Are Women Still Missing from Cardiovascular Clinical Trials?
Women remain underrepresented in heart disease research after decades of efforts to correct the balance, affecting trial data and women's cardiovascular care.
Strong Link Between Increasing Lp(a) Level and Recurrent ASCVD Events Makes Screening Essential, Investigator Warns
A continuous increase in ASCVD risk was seen with higher levels of lipoprotein(a) in the largest study to date of the relationship.
IPF Update: FIBRONEER-IPF Study of Nerandomilast Meets Primary End Point
The positive pivotal phase 3 trial results showed improved lung function with neradomilast vs placebo and will support BI's US and global NDA submissions.
WHO Issues Medical Product Alert for Counterfeit Semaglutide
Three falsified batches of semaglutide (Ozempic) are in circulation, posing risks for ineffective treatment due to incorrect dosing, contamination, and use of unknown ingredients, warned WHO.
GALACTIC Trial: RAAS Inhibitor Uptitration Less Successful in Women
Uptitration of renin-angiotensin-aldosterone system inhibitors was less successful in women with acute heart failure, and particularly those with heart failure with reduced ejection fraction.
Diabetes- and CVD-Related Mortality Rise after Steady 10-Year Decline
Since 2014, the age-adjusted mortality rate for diabetes and CVD has increased by 1% after an overall decline between 1999 and 2019, new research finds.
Concentrated and Distributed Physical Activity Similarly Lower Risk for CV Events
Regardless of the pattern of physical activity, it may reduce risk across a spectrum of cardiovascular diseases, say study authors. So, just do it!
ADA Updates Standards of Care, Adding Teplizumab for Delay of T1D, Emphasizing Hepatic Disease Management
The ADA's annual update includes refined criteria for type 1 diabetes screening and detailed guidance on detection and management of NAFLD and NASH.
Metabolic Surgery May Help Mitigate Microvascular Damage in Persons with Diabetes
Among other improvements, bariatric surgery may help reverse peripheral neuropathy and stabilize cardiovascular autonomic neuropathy, according to new findings.
